Prediction of the progression from mild cognitive impairment to Alzheimer's disease using a radiomics-integrated model.

The integrated model based on whole-brain radiomics can accurately identify and predict the high-risk population of MCI patients who may progress to AD. Radiomics biomarkers are practical in the precursory stage of such disease.